Merit Medical prelim FY2024 rev ~$1.356B, up 7.7-7.9% YoY; full results Feb 25

MERIT MEDICAL SYSTEMS INC

Preliminary unaudited revenue $1.355B-$1.357B for FY2024, up ~7.7%-7.9% YoY.
Constant currency rev growth 8.4-8.6% YoY; FX impact of $7.9M on reported rev.
Plans to report Q4/FY2024 results and issue FY2025 guidance on Feb 25, 2025 after market close.
Conference call Feb 25, 2025 at 5:00 PM Eastern; registration link available.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.